HealthEquity’s (HQY) “Outperform” Rating Reiterated at Barrington Research

HealthEquity (NASDAQ:HQY – Get Free Report)‘s stock had its “outperform” rating reissued by stock analysts at Barrington Research in a research note issued to investors on Friday,Benzinga reports. They currently have a $125.00 target price on the stock. Barrington Research’s price target would suggest a potential upside of 39.93% from the company’s previous close. Other […]

Leave a Reply

Your email address will not be published.

Previous post Karooooo (NASDAQ:KARO) Coverage Initiated by Analysts at UBS Group
Next post Viant Technology (NASDAQ:DSP) Now Covered by Analysts at DA Davidson